Orthopedic surgery implications of breast cancer

References

• Ngoma T. World Health Organization cancer priorities in developing countries. Ann. Oncol.17(Suppl. 8), viii9–viii14 (2006).
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin.57(1), 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Weber KL, Lewis VO, Randall RL, Lee AK, Springfield D. An approach to the management of the patient with metastatic bone disease. Instructional course lectures.53, 663–676 (2004).
   PubMedGoogle Scholar
• Lu X, Kang Y. Organotropism of breast cancer metastasis. J. Mammary Gland Biol. Neoplasia12(2–3), 153–162 (2007).
   PubMed Web of Science ®Google Scholar
• Guise TA, Mundy GR. Cancer and bone. Endocrine Rev.19(1), 18–54 (1998).
   PubMed Web of Science ®Google Scholar
• Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. Eur. J. Surg. Oncol.33(4), 420–423 (2007).
   PubMed Web of Science ®Google Scholar
• Vogel CL, Azevedo S, Hilsenbeck S, East DR, Ayub J. Survival after first recurrence of breast cancer. The Miami experience. Cancer70(1), 129–135 (1992).
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Ueo H, Tsuji K, Tokunaga E, Baba H, Maehara Y. Prediction of survival from first recurrence of breast carcinoma in Japanese women. Breast15(2), 226–231 (2006).
   PubMed Web of Science ®Google Scholar
• Choi BS, Robins HI. Primary disease resection in metastatic breast cancer improves survival. J. Clin. Oncol.25(5), 603–604 (2007).
   PubMedGoogle Scholar
• Jubelirer SJ, Wilson R, Summers L, Richardson S. Prognostic factors determining survival in breast cancer patients presenting with metastatic disease. W. V. Med. J.86(1), 7–9 (1990).
   PubMedGoogle Scholar
• Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists’ Collaborative Group overview. Ann. Oncol.17(Suppl. 10), x59–x62 (2006).
   Web of Science ®Google Scholar
• Goldhirsch A, Gelber RD, Coates AS. What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer? Nat. Clin. Pract.2(9), 440–441 (2005).
   PubMedGoogle Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet365(9472), 1687–1717 (2005).
   PubMed Web of Science ®Google Scholar
• Yamashita K, Koyama H, Inaji H. Prognostic significance of bone metastasis from breast cancer. Clin. Orthop. Relat. Res. (312), 89–94 (1995).
   PubMedGoogle Scholar
• Diel IJ, Solomayer EF, Bastert G. Treatment of metastatic bone disease in breast cancer: bisphosphonates. Clin. Breast Cancer1(1), 43–51 (2000).
   PubMedGoogle Scholar
• Frassica FJ, Frassica DA, McCarthy EF, Riley LH III. Metastatic bone disease: evaluation, clinicopathologic features, biopsy, fracture risk, nonsurgical treatment, and supportive management. Instructional course lectures49, 453–459 (2000).
   PubMedGoogle Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev.2(8), 584–593 (2002).
   Google Scholar
• Kuperwasser C, Dessain S, Bierbaum BE et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res.65(14), 6130–6138 (2005).
   PubMed Web of Science ®Google Scholar
• Quattrocchi CC, Piciucchi S, Sammarra M et al. Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Radiol. Med. (Torino)112(7), 1049–1059 (2007).
   PubMed Web of Science ®Google Scholar
• Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat.32(1), 73–84 (1994).
   PubMed Web of Science ®Google Scholar
• Kominsky SL, Davidson NE. A “bone” fide predictor of metastasis? Predicting breast cancer metastasis to bone. J. Clin. Oncol.24(15), 2227–2229 (2006).
   PubMed Web of Science ®Google Scholar
• Yang W, Lam P, Kitching R et al. Breast cancer metastasis in a human bone NOD/SCID Mouse Model. Cancer Biol. Ther.6(8), 1289–1294 (2007).
   PubMed Web of Science ®Google Scholar
• Bendre M, Gaddy D, Nicholas RW, Suva LJ. Breast cancer metastasis to bone: it is not all about PTHrP. Clin. Orthop. Relat. Res. (415 Suppl.), S39–45 (2003).
   Google Scholar
• Slade MJ, Coombes RC. The clinical significance of disseminated tumor cells in breast cancer. Nat. Clin. Pract.4(1), 30–41 (2007).
   Google Scholar
• Singh B, Berry JA, Shoher A, Ayers GD, Wei C, Lucci A. COX-2 involvement in breast cancer metastasis to bone. Oncogene26(26), 3789–3796 (2007).
   PubMed Web of Science ®Google Scholar
• Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin. Orthop. Relat. Res.355 (Suppl.), S314–S335 (1998).
   PubMed Web of Science ®Google Scholar
• Verdijk R, Franke HR, Wolbers F, Vermes I. Differential effects of bisphosphonates on breast cancer cell lines. Cancer Lett.246(1–2), 308–312 (2007).
   PubMed Web of Science ®Google Scholar
• Pritchard KI. Bisphosphonates: are they standard of care for the treatment of breast cancer? Br. J. Cancer96(12), 1781–1782 (2007).
   PubMed Web of Science ®Google Scholar
• Durr HR, Muller PE, Lenz T, Baur A, Jansson V, Refior HJ. Surgical treatment of bone metastases in patients with breast cancer. Clin. Orthop. Relat. Res. (396), 191–196 (2002).
   PubMedGoogle Scholar
• Briasoulis E, Karavasilis V, Kostadima L, Ignatiadis M, Fountzilas G, Pavlidis N. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer101(7), 1524–1528 (2004).
   PubMed Web of Science ®Google Scholar
• Samsani SR, Panikkar V, Venu KM, Georgiannos D, Calthorpe D. Breast cancer bone metastasis in femur: surgical considerations and reconstruction with Long Gamma Nail. Eur. J. Surg. Oncol.30(9), 993–997 (2004).
   PubMed Web of Science ®Google Scholar
• Zindrick MR, Young MP, Daley RJ, Light TR. Metastatic tumors of the foot: case report and literature review. Clin. Orthop. Relat. Res. (170), 219–225 (1982).
   PubMedGoogle Scholar
• Asthana S, Deo SV, Shukla NK, Raina V. Carcinoma breast metastatic to the hand and the foot. Australas. Radiol.45(3), 380–382 (2001).
   PubMedGoogle Scholar
• Abe K, Sasaki M, Kuwabara Y et al. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann. Nucl. Med.19(7), 573–579 (2005).
   PubMed Web of Science ®Google Scholar
• Hardisty M, Gordon L, Agarwal P, Skrinskas T, Whyne C. Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. Med. Phys.34(8), 3127–3134 (2007).
   PubMed Web of Science ®Google Scholar
• Schirrmeister H. Detection of bone metastases in breast cancer by positron emission tomography. Rad. Clin. North Am.45(4), 669–676, vi (2007).
   PubMed Web of Science ®Google Scholar
• Begic A, Kucukalic-Selimovic E, Obralic N et al. Role of bone scintigraphy and tumor marker-Ca 15–3 in detection of bone metastases in patients with breast cancer. Bosn. J. Basic Med. Sci.5(1), 23–26 (2005).
   PubMedGoogle Scholar
• Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J. Clin. Oncol.22(14), 2942–2953 (2004).
   PubMed Web of Science ®Google Scholar
• Raileanu I, Rusu V, Talbot JN et al. [Correlation in imaging techniques for the early detection of bone metastases in a case of breast cancer]. Rev. Med. Chir. Soc. Med. Nat. Iasi.108(1), 210–213 (2004).
   PubMedGoogle Scholar
• Muindi J, Coombes RC, Golding S, Powles TJ, Khan O, Husband J. The role of computed tomography in the detection of bone metastases in breast cancer patients. Br. J. Radiol.56(664), 233–236 (1983).
   PubMed Web of Science ®Google Scholar
• British Association of Surgical Oncology Guidelines. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oncology. Eur. J. Surg. Oncol.25(1), 3–23 (1999).
   PubMedGoogle Scholar
• Bristow AR, Agrawal A, Evans AJ et al. Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study. Breast17(1), 98–103 (2007).
   PubMed Web of Science ®Google Scholar
• Ghanem N, Altehoefer C, Kelly T et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In vivo (Athens, Greece)20(1), 173–182 (2006).
   PubMed Web of Science ®Google Scholar
• Lauenstein TC, Goehde SC, Herborn CU et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology233(1), 139–148 (2004).
   PubMed Web of Science ®Google Scholar
• Tafra L. Positron emission tomography (PET) and mammography (PEM) for breast cancer: importance to surgeons. Ann. Surg. Oncol.14(1), 3–13 (2007).
   PubMedGoogle Scholar
• Yang SK, Cho N, Moon WK. The role of PET/CT for evaluating breast cancer. Korean J. Radiol.8(5), 429–437 (2007).
   PubMed Web of Science ®Google Scholar
• Gainford MC, Dranitsaris G, Clemons M. Systemic treatment of bone metastases from breast cancer: is it all that it’s cracked up to be? J. Clin. Oncol.23(21), 4802–4803 (2005).
   PubMed Web of Science ®Google Scholar
• Ripamonti C, Fulfaro F. Malignant bone pain: pathophysiology and treatments. Curr. Rev. Pain4(3), 187–196 (2000).
   PubMedGoogle Scholar
• Layman R, Olson K, Van Poznak C. Bisphosphonates for breast cancer: questions answered, questions remaining. Hematol. Oncol. Clin. North Am.21(2), 341–367 (2007).
   PubMed Web of Science ®Google Scholar
• Kakonen SM, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer97(3 Suppl.), 834–839 (2003).
   PubMed Web of Science ®Google Scholar
• Bauman G, Charette M, Reid R, Sathya J. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother. Oncol.75(3), 258–270 (2005).
   PubMed Web of Science ®Google Scholar
• Fidler M. Incidence of fracture through metastases in long bones. Acta Orthop. Scand.52(6), 623–627 (1981).
   PubMed Web of Science ®Google Scholar
• Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin. Orthop. Relat. Res.249, 256–264 (1989).
   Google Scholar
• Weber KL, Randall RL, Grossman S, Parvizi J. Management of lower-extremity bone metastasis. J. Bone Joint Surg. Am.88(Suppl. 4), 11–19 (2006).
   PubMedGoogle Scholar
• Mirels H. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures. 1989. Clin. Orthop. Relat. Res.415(Suppl.), S4–13 (2003).
   Web of Science ®Google Scholar
• Adami HO, Zack M, Kressner U et al. Hip fractures in women with breast cancer. Am. J. Epidemiol.132(5), 877–883 (1990).
   PubMed Web of Science ®Google Scholar
• Tillman RM. The role of the orthopaedic surgeon in metastatic disease of the appendicular skeleton. Working Party on Metastatic Bone Disease in Breast Cancer in the UK. J. Bone Joint Surg. Br.81(1), 1–2 (1999).
   PubMedGoogle Scholar
• Randall RL, Aoki SK, Olson PR, Bott SI. Complications of cemented long-stem hip arthroplasties in metastatic bone disease. Clin. Orthop. Relat. Res.443, 287–295 (2006).
   PubMedGoogle Scholar
• Eckardt JJ, Kabo JM, Kelly CM, Ward WG Sr, Cannon CP. Endoprosthetic reconstructions for bone metastases. Clin. Orthop. Relat. Res.415(Suppl.), S254–S262 (2003).
   Google Scholar